Artificial Intelligence-Assisted Team-Based and Case-Based Learning in Neurosurgery Clinical Education (AI-TBL-CBL)

November 10, 2026 updated by: Xuejian Wang, Nantong First People's Hospital

Application of an Artificial Intelligence-Assisted Team-Based and Case-Based Learning Teaching Model in Neurosurgery Clinical Education: A Non-Randomized Controlled Study

This study compared an artificial intelligence (AI)-assisted teaching model that combined team-based learning (TBL) and case-based learning (CBL) with TBL and CBL alone during a neurosurgery internship. The primary outcomes were theoretical examination scores and clinical skill assessment scores; teaching satisfaction was a secondary outcome.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Two intact classes of undergraduate medical interns (n = 75) completed their neurosurgery rotation at a tertiary hospital in Nantong, Jiangsu, China, between September 2025 and May 2026. Because the rotation was organized by class and the classes could not be split, one class received artificial intelligence (AI)-assisted team-based learning (TBL) and case-based learning (CBL) (n = 38) and the other class received TBL and CBL alone (n = 37). In the experimental class, a general-purpose large language model (Tencent Yuanbao) was available at every teaching stage, and teachers reviewed the model output with the students before it was used. Outcomes were measured at the end of the rotation. The design was non-randomized and unblinded, and academic performance before the rotation was not recorded; differences therefore cannot be attributed to the AI component alone.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Nantong, Jiangsu, China, 226000
        • Nantong First People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Undergraduate medical intern
  • Completed the full neurosurgery rotation at Nantong First People's Hospital between September 2025 and May 2026
  • Enrolled in one of the two intact classes that took part in the study
  • Provided written informed consent

Exclusion Criteria:

- None; all interns in the two classes were included

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: artificial intelligence-assisted team-based and case-based learning

One intact class of undergraduate medical interns received the standard five-stage team-based learning (TBL) and case-based learning (CBL) neurosurgery curriculum, with a general-purpose large language model (Tencent Yuanbao) available at every stage. Students used the model to retrieve cases and guidelines before class, compare readiness-test answers, discuss operative decisions, review procedural steps and summarize key points. Teachers reviewed the model output with the students and did not accept model answers as the final answer.

Students prepared in advance and completed individual readiness assurance tests (iRAT) and team readiness assurance tests (tRAT) in small teams, followed by team discussion of the prepared material and a summary with feedback at the end of each cycle. Delivered to both arms.

Teaching was organized around typical neurosurgical cases, for example supratentorial tumors and acute subdural hematoma. Teams worked through diagnosis, imaging interpretation, surgical indications and choice of procedure, then completed case analysis and clinical skills practice. Delivered to both arms.

Students used a general-purpose large language model (Tencent Yuanbao) at every teaching stage: retrieving related cases and current guidelines before class, comparing readiness-test answers, structuring case discussions and locating supporting evidence, reviewing procedural steps, and compiling summaries of weak points. Teachers reviewed the model output with students and did not accept model answers as the final answer. Delivered to the experimental arm only.

Active Comparator: Active Comparator: team-based and case-based learning alone

The other intact class followed the same five-stage TBL and CBL curriculum without artificial intelligence assistance. The same teaching team delivered both curricula.

Students prepared in advance and completed individual readiness assurance tests (iRAT) and team readiness assurance tests (tRAT) in small teams, followed by team discussion of the prepared material and a summary with feedback at the end of each cycle. Delivered to both arms.

Teaching was organized around typical neurosurgical cases, for example supratentorial tumors and acute subdural hematoma. Teams worked through diagnosis, imaging interpretation, surgical indications and choice of procedure, then completed case analysis and clinical skills practice. Delivered to both arms.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Theoretical examination score
Time Frame: At the end of the neurosurgery rotation (up to 9 months)

Score from 0 to 100 on a written examination covering neuroanatomy, pathophysiology and clinical case analysis. Items were drawn from the neurosurgery question bank of the Medical Licensing Examination and marked against a standard answer key.

At the end of the neurosurgery rotation (up to 9 months)
Clinical skill assessment score
Time Frame: At the end of the neurosurgery rotation (up to 9 months)

Score from 0 to 100 on a structured clinical skills assessment covering lumbar puncture, neurological examination, computed tomography (CT) and magnetic resonance imaging (MRI) review, case analysis and demonstration of craniotomy steps. Scored with the departmental checklist.

At the end of the neurosurgery rotation (up to 9 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Teaching satisfaction
Time Frame: At the end of the neurosurgery rotation (up to 9 months)

Total score from 0 to 36 on an 18-item, six-domain departmental questionnaire covering learning motivation, knowledge retention, problem analysis and solving, breadth of knowledge, innovative thinking, and teamwork and communication. Overall satisfaction was defined as a total score of 18 or above.

At the end of the neurosurgery rotation (up to 9 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2025

Primary Completion (Actual)

May 31, 2026

Study Completion (Actual)

May 31, 2026

Study Registration Dates

First Submitted

October 29, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-KT309-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared; de-identified summary data are provided in the publication and supplementary files.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.